Involvement of CD147 in overexpression of MMP-2 and MMP-9 and enhancement of invasive potential of PMA-differentiated THP-I

被引:83
作者
Zhou, J
Zhu, P
Jiang, JL
Zhang, Q
Wu, ZB
Yao, XY
Tang, H
Lu, N
Yang, Y
Chen, ZN
机构
[1] Fourth Mil Med Univ, Affiliated Hosp 1, Dept Clin Immunol, Xian 710032, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Dept Cell Biol, Cell Engn Res Ctr, Xian 710032, Shaanxi, Peoples R China
[3] Xian Jiaotong Univ, Sch Med, Dept Pharmacol, Xian 710061, Shaanxi, Peoples R China
关键词
D O I
10.1186/1471-2121-6-25
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: During infection and inflammation, circulating blood monocytes migrate from the intravascular compartments to the extravascular compartments, where they mature into tissue macrophages. The maturation process prepares the cells to actively participate in the inflammatory and immune responses, and many factors have been reported to be involved in the process. We found in our study that CD147 played a very important role in this process. Results: By using PMA-differentiated human monocyte cells line THP-I, we found that CD147 mediated matrix metalloproteinases (MMPs) expression of the leukemic THP-I cells and thus enhanced the invasiveness of THP-I cells. After 24 hours of PMA-induced monocyte differentiation, the mean fluorescence intensity of CD147 in differentiated THP-I cells ( 289.61 +/- 31.63) was higher than that of the undifferentiated THP-I cells ( 205.1 +/- 19.25). There was a significant increase of the levels of proMMP-2, proMMP-9 and their activated forms in the differentiated THP-I cells. Invasion assays using reconstituted basement membrane showed a good correlation between the invasiveness of THP-I cells and the production of MMP-2 and MMP-9. The difference in the MMPs expression and the invasive ability was significantly blocked by HAb18G/ CD147 antagonistic peptide AP-9. The inhibitory rate of the secretion of proMMP-9 in the undifferentiated THP-I cells was 45.07%. The inhibitory rate of the secretion of proMMP-9, the activated MMP-9 and proMMP2 in the differentiated THP-I cells was 52.90%, 53.79% and 47.80%, respectively. The inhibitory rate of invasive potential in the undifferentiated cells and the differentiated THP-I cells was 41.82 % and 25.15%, respectively. Conclusion: The results suggest that the expression of CD147 is upregulated during the differentiation of monocyte THP-I cells to macrophage cells, and CD147 induces the secretion and activation of MMP-2 and MMP-9 and enhances the invasive ability of THP-I cells. The matured monocytes / macrophages, via their high expression of CD147, may play an important role in promoting the tissue repair or tissue damage during their inflammatory response.
引用
收藏
页数:10
相关论文
共 33 条
[1]  
AGUER MJ, 1992, MACROPHAGE, P3
[2]  
AMORLINO GP, 1998, AM J PATHOL, P199
[3]  
BISWAS C, 1995, CANCER RES, V55, P434
[4]   Application of cell engineering technology to the tumour immunotherapeutic drug: A review [J].
Chen, ZN ;
Xing, JL ;
Bian, HJ ;
Mi, L ;
Jiang, JL .
CELL BIOLOGY INTERNATIONAL, 2001, 25 (10) :1013-1015
[5]  
CHEN ZN, 2003, J TUMOR MARKER ONCOL, V18, P5
[6]   Quantification of basigin mRNA in mouse oocytes and preimplantation embryos by competitive RT-PCR [J].
Ding, NZ ;
He, CQ ;
Yang, ZM .
ZYGOTE, 2002, 10 (03) :239-243
[7]   INCREASED EXPRESSION OF MATRIX METALLOPROTEINASES AND MATRIX-DEGRADING ACTIVITY IN VULNERABLE REGIONS OF HUMAN ATHEROSCLEROTIC PLAQUES [J].
GALIS, ZS ;
SUKHOVA, GK ;
LARK, MW ;
LIBBY, P .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2493-2503
[8]   MACROPHAGE FOAM CELLS FROM EXPERIMENTAL ATHEROMA CONSTITUTIVELY PRODUCE MATRIX-DEGRADING PROTEINASES [J].
GALIS, ZS ;
SUKHOVA, GK ;
KRANZHOFER, R ;
CLARK, S ;
LIBBY, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) :402-406
[9]   Characterization of matrix metalloproteinases produced by rat alveolar macrophages [J].
Gibbs, DF ;
Warner, RL ;
Weiss, SJ ;
Johnson, KJ ;
Varani, J .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (06) :1136-1144
[10]  
Guo HM, 2000, CANCER RES, V60, P888